It has been known for some period of time that activation of the complement system leads to the appearance of peptides (especially the C5a anaphylatoxin) that have the ability to stimulate leukocytes (neutrophils, monocytes and macrophages), resulting in secretion of lysosomal enzymes, appearance of arachidonate products and the generation of toxic oxygen products. There is now rather convincing evidence that when this occurs in vivo within the lung serious consequences may ensue, including acute lung injury and compromised respiratory function.
"Toxic oxygen products" refer to a sequence of derivatives from molecular oxygen to which electrons have been added sequentially, as described in Figure  1 . The addition of a single electron to O2 results in the first free radical of oxygen, O2 or superoxide anion. The definition of a free radical is a molecule with an unpaired electron in the outer orbit. As such, a free radical is unstable and will tend either to give up its 0 2 Molecular (fully oxidized) oxygen unpaired electron (thus acting as a reducing agent) or it will take on another electron, resulting in an oxidation of the electron donor. 02 is moderately unstable. If an electron is added, it becomes converted to HEO2, which is a rather stable and freely diffusible product. The addition of a third electron, which is facilitated by the presence of Fe 2 + in the classical Fenton reaction, results in formation of the extremely unstable hydroxyl radical (HO'), which is a powerful oxidant because of its ability to accept an electron resulting in conversion to HE0. Hydroxyl radical-mediated peroxidation of lipid and protein constituents of biological membranes may ultimately lead to cell and tissue damage. Because of its great instability, HO" will induce damage only if its target is in extremely close proximity to the source of HO'. As a result of stimulation of neutrophils, monocytes or macrophages via interaction of C5a with cell membrane receptors, a sequence of events occurs as shown in Figure 2 . These events result in activation of NADPH oxidase, which is a cell membrane-associated enzyme. This leads to the generation of the family of toxic oxygen products on the surface of the stimulated phagocytic cell, as described in Figure 2 . Included in this diagram is another oxygen product, singlet oxygen (102) which is probably responsible for the phenomenon of chemiluminescence. Singlet oxygen is not a free radical; it is a species of oxygen in which an electron has moved into an outer orbital position. This abnormally positioned electron has a tendency to fall back into its natural orbital configuration, resulting in the release of energy which can be measured as chemiluminescence. Stimulation of the surface of the leukocyte to generate these oxygen products also resuits in the release of the lysosomal enzyme myeloperoxidase, which, in the presence of halides such as chloride, can convert H202 to hypochlorous acid (HOC1), another powerful oxidant.
There is good evidence that these toxic oxygen~ products from stimulated phagocytic cells can be produced in vivo within the lung, resulting in acute ~ lung injury. An experimental model in which this has been demonstrated is associated with intravascular activation of the complement system following the intravenous infusion of cobra venom factor [18] . The pathogenesis of the reaction is outlined in Figure 3 , where intravascular appearance of C5a leads to activation and aggregation of neutrophils and the entrapment of these cell clusters within interstitial pulmonary capillaries. Within the pulmonary vasculature endothelial cells in contact with these activated neutrophils develop morphological evidence of damage or necrosis. As a consequence of this injury, interstitial edema together with intraalveolar edema and hemorrhage rapidly develop. The conclusion that pulmonary endothelial cell injury is due to HO" generation by neutrophils is based on the protective effects of neutrophil depletion as well as the beneficial effects of treatment with catalase (which destroys H202), iron chelators or scavengers of the hydroxyl radical [19] . This model of acute lung injury mediated by complement activation products and toxic oxygen products from neutrophils provides support for the earlier observations of Craddock and colleagues who noted evidence of acute pulmonary dysfunction in patients undergoing hemodialysis and demonstrated that contact of plasma with dialysis membranes resuits in complement activation, leukoaggregation and intrapulmonary entrapment of these cells [3, 4] . It has been argued that abnormalities in blood gases of patients undergoing hemodialysis may be the result of gas diffusion when blood passes through the dialyzer apparatus, rather than a reflection of injury to the lung. It appears likely that hemodialysis per se is not a significant risk for lung damage since the amount of activation of the complement system is quite limited and probably not sufficient to activate neutrophils for oxygen radical production. Nevertheless, under certain conditions intravascular activation of the complement system has the potential, through the mechanisms described above, to cause acute lung injury. A similar pathogenesis for acute lung injury following the intravenous injection of complement-activated plasma into rabbit or sheep has been suggested [9, 15, 16] . It is now considered that analogous mechanisms may be responsible for the adult respiratory distress syndrome (ARDS) in humans. This speculation is based on evidence of consumptive depletion of the complement system coupled with the presence of C5a in the serum (or plasma) of patients with ARDS [7] . In addition, the bronchoalveolar lavage fluid of these individuals contains inactive ~l-antiproteinase (which has been oxidatively inactivated) and the presence of leukocytic elastase which normally is not detectable in these fluids [2, 14] . It is now established that plasma levels of complement anaphylatoxins (C3a, C5a) do not discriminate between those patients who will and those who will not develop ARDS [5, 21] . Increases in plasma level of C3a occur in both groups while C5a cannot be detected, probably because of its rapid interaction with receptors on circulating neutrophils, eosinophils and monocytes. The recent studies of Henson et al. [8] suggest that, at least in the rabbit, complement activation within the vascular compartment only leads to acute lung injury if there is preexisting exposure to PGE2 or if the lung has been subjected to hypoxic conditions. In other words, the lung may ordinarily be resistant to complement-mediated injury and only susceptible to injury after prior exposure to some compromising condition.
Another experimental model in which complement activation may lead to acute pulmonary dysfunction and injury follows the intrapulmonary deposition of immune complexes, which have the ability to activate the complement system. In this model IgG antibody is injected into the distal airway system by bolus instillation during inhalation and antigen is injected intravenously, or vice versa. The result is immune complex deposition in the lung interstitium and along alveolar walls. In situ deposition within lung of immune complexes results in an activation of the complement system, a marked increase in vas0perme-ability, and the rapid mobilization of neutrophils (via the chemotactic peptide C5a) into areas containing deposits of immune complexes [10] . The outcome of these events is a rapid and large accumulation of neutrophils within the alveolar compartment, the functional activation of these neutrophils both by C5a as well as by immune complexes, and the secretory release of lysosomal constituents (including proteases) and generation of toxic oxygen radicals from activated neutrophils [11] . The consequence of these events is immediate: the alveolar compartment becomes filled with neutrophils, red cells, protein and water, resulting in acute respiratory dysfunction as evidenced by tachypnea and hypoxemia.
The pathogenesis of the lung injury following deposition of IgG immune complexes has been studied rather intensively. Blockade of the complement system of neutrophil depletion prior to tissue deposition of immune complexes protects against the development of tissue injury [10] . Furthermore, treatment of the animals with catalase is protective [11] . Interventions with superoxide dismutase also have some limited protective value [13] . A more precise definition of the oxygen products involved in immune complex-induced lung injury is not available at the present time. Although the production of H202 from activated neutrophils is obviously related to the ultimate development of injury, whether H202 is reduced to HO" in the presence of iron, is enzymatically converted by myeloperoxidase to HOCI, or is altered into some other toxic species cannot be determined at the present time.
In IgG-immune-complex-initiated acute lung injury, alveolar and perhaps also interstitial macrophages have the potential to add to the level of toxic oxygen products being produced in addition to those oxygen radicals generated by activated neutrophils. It is known that alveolar macrophages, like neutrophils, can be directly stimulated in vitro by immune complexes to produce toxic oxygen products [20] . Whether complement activation products are effective agonists for oxygen radical formation by alveolar macrophages is not known. The extent to which the lung macrophage contributes to lung injury produced by IgG immune complexes is unclear. The protective effects afforded by neutrophil depletion or by treatment with catalase suggest that, on balance, the ultimate pathogenesis of lung injury caused by immune complex deposits can be attributed to the family of toxic oxygen products from neutrophils.
Recently in another model of immune complex-induced acute lung injury in rats utilizing IgA immune complexes from monoclonal antibody of murine origin, it has been demonstrated that, in contrast to IgGimmune-complex-induced lung injury, immune complexes consisting of IgA cause acute lung injury but Table 2) . It has recently been demonstrated that prior exposure of hemoglobin, fibrinogen or elastin to micromolar concentration of H202 will greatly enhance the ability of leukocytic proteases to degrade these substrates [6] . In addition, incubation of macrophages with leukocytic proteases followed by washing and exposure of these cells to phorbol myristate acetate causes a marked increase in the amounts of oxygen metabolites generated [17] . The mechanism by which this occurs is entirely unknown at the present time. The well-established ability of oxygen products from neutrophils to oxidatively inactivate ed-antiproteinase [1] is another mechanism by which oxygen radicals from stimulated phagocytic cells can potentiate the effects of leukocytic proteinases.
As the experimental models demonstrate, acute lung injury can be induced by a variety of experimental conditions in which the complement system comes into play as a vital mediator pathway. The evidence is overwhelming that complement activation products are not themselves tissue damaging; their ultimate damaging effects are brought about through their ability to trigger activation of phagocytic cells, both neu- Table 2 . Synergism between oxygen radicals and leukocytic proteases 1. Oxygen radicals enhance substrate hydrolysis by leukocytic proteases 2. Leukocytic proteases enhance oxygen radical generation from macrophages 3. Oxygen radicals chemically inactivate cd-antiproteinase trophils and macrophages, resulting in the appearance of toxic oxygen products and release of lysosomal enzymes. A more detailed understanding of these events will provide a variety of mechanisms for protective interventions in human diseases.
